Welcome to our dedicated page for ORGANTO FOODS news (Ticker: OGOFF), a resource for investors and traders seeking the latest updates and insights on ORGANTO FOODS stock.
Organto Foods Inc. supplies certified organic and fairtrade produce to international retailers through a model built around global sourcing, logistics, and distribution. Company news commonly covers European retail programs, grower and supply partnerships, logistics capacity, and the expansion of its fresh produce platform.
Updates also address audited financial results prepared under IFRS, financing facilities for European foods operations, warrant exercises and other capital actions, leadership appointments, marketing and market-making engagements, and participation in fresh produce industry events.
Organto Foods (OGOFF) renewed its research services agreement with Atrium Research Corporation, effective September 15, 2026, for a 12‑month term at $2,500 per month, subject to TSXV approval.
Atrium will publish research reports based on public information, industry data and management discussions, and will host interviews with Organto’s management to present its investment case in organic and sustainable foods. Organto reports that 2026 first‑half sales increased 73% versus the prior year, with an annualized sales run rate now above $100 million. Gross profit and EBITDA reached record levels, while working capital was $15.3 million with no long‑term debt at the end of the second quarter. Both adjusted gross profit and EBITDA are presented as non‑IFRS measures, used by management to better track operating performance over time.
Organto Foods (OGOFF) will participate in the Fruit Attraction 2026 trade show in Madrid, Spain, from October 6 to 8, 2026.
The company and its New Fruit Group subsidiary will use the event to meet retail customers and supply partners, pursue strategic initiatives and showcase their integrated global sourcing and distribution model for organic and fairtrade produce. Visitors can meet the teams at Stand B11 in Hall 12. Organto reports that its integrated ecosystem delivered approximately 73% year-over-year sales growth through the second quarter of 2026 and positive EBITDA, compared with an EBITDA loss in the prior-year period.
Organto Foods (OTCQX:OGOFF) reported record Q2 2026 results, with sales up approximately 61% year-over-year to $27.7 million, the largest quarterly revenue in its history. Gross profit rose about 65% to $2.1 million (7.5% margin), while adjusted gross profit reached $2.2 million (7.8% margin), up roughly 204% versus the prior year.
EBITDA improved to a record positive $0.4 million, compared to a loss of $0.5 million a year earlier, and net loss from continuing operations narrowed to $0.1 million. For the first six months of 2026, sales increased about 73% to $53.3 million and gross profit to $3.9 million. According to Organto, working capital stood at $15.3 million, cash at $5.4 million, equity at $16.4 million (up 87% in 2026), with no long-term debt and an annualized sales run rate exceeding $100 million.
Organto Foods (OTCQX:OGOFF) reported results of its June 24, 2026 Annual General Meeting. Shareholders voted 128,589,289 common shares, about 67.82% of eligible shares, with all matters receiving over 99% support.
Six directors were elected, the auditor reappointed, equity plans renewed, and 350,000 options plus 650,000 RSUs were granted.
Organto Foods (OTCQX:OGOFF) appointed Darryl Bergman as President, effective June 1, 2026. He will report to Co-Chair and CEO Steve Bromley, focusing on core operations, expansion and strategic growth.
Organto highlighted record first-quarter sales, an EBITDA-positive quarter, and weekly sales of about CAD $2 million, implying an annual run-rate above CAD $100 million.
Organto Foods (OTCQX:OGOFF) reported record Q1 2026 sales of $25.6 million, up about 88% year-over-year, with the largest quarterly revenue and gross profit in its history. Gross profit reached $1.8 million (7.1% margin) and EBITDA was approximately $0.1 million.
Cash operating costs were 6.2% of sales, down from 6.5%. Working capital rose to $14.5 million and net equity to $15.7 million, with no long-term debt outstanding. Net loss from continuing operations was approximately $0.0 million.
Organto Foods (TSXV:OGO / OTCQX:OGOFF) announced audited results for the year ended December 31, 2025. Fiscal 2025 sales reached $60.9M (≈194% YoY), gross profit $5.2M, EBITDA of $(1.15)M, and cash of $5.7M. Balance sheet strengthened via debt restructuring and equity issuance.
Working capital improved to $7.6M and net equity to $8.8M; net loss included non-cash restructuring and settlement items.
Organto Foods (TSX-V:OGO; OTCQX:OGOFF) expanded its European financing facility with Rabobank, increasing the flexible funding line from €4 million to €7 million to support operational growth. The facility is collateralized by a €630,000 deposit, bears one-month EURIBOR plus a margin, and expires November 2027 with automatic one-year renewals unless terminated.
Organto reported weekly sales of approximately CDN $2 million (about a CDN $100 million annual run rate) and confirmed an administrative correction to incentive warrants issued under an earlier program.
Organto (OTCQX:OGOFF) expanded its leadership team and operational structure to support rapid commercial growth, reporting weekly sales near CDN $2 million (approximate annual run rate of CDN $100 million).
Key promotions include new SVP roles for European operations and business development, a director for digital technology and business controlling, and a shift of the COO to focus on M&A and treasury. The company also terminated its engagement with Machai Capital; the initial $100,000 payment was returned and a previously announced stock option grant was cancelled.
Organto Foods (OTCQX:OGOFF) engaged London-based VSA Capital for marketing and communications and Venture Liquidity Providers (VLP) for market-making services.
VSA will produce video and podcast content through March 2027 for an annual fee of GBP 7,000 plus VAT. VLP will provide market-making via W.D. Latimer starting April 1, 2026 for $5,000 per month (initial 3-month term). Both agreements auto-renew and are subject to TSX Venture Exchange acceptance.